A 76-year-old woman presents with a persistently rapid heart rate that she attributes to her pacemaker. What does the ECG show?

Affecting 1 in 500 people, hypertrophic cardiomyopathy is a condition in which the walls of the left ventricle, the heart's ...

Researchers determine the role of dietary omega-3 fatty acids in the development of ischemic heart disease throughout the ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Researchers in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions report a ...

The evidence discussed in this section relating to cardiomyopathy and HF is summarized ... it is now understood that the immune response in the ischemic or infarcted heart plays a critical role in ...

cardiac resynchronization therapy-defibrillator; CVB3, coxsackievirus B3; DAPA-HF, Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure; DCM, dilated cardiomyopathy; DSP, desmoplakin; E2, ...

Heart failure was only 3.6 times higher (HR 3.63), which is surprising considering that cardiomyopathy risk was nearly nine times higher in this group (HR 8.90). Researchers concluded that AAS use ...

Hypertrophic cardiomyopathy (HCM ... as measured by an electrocardiograph (ECG) heart imaging that shows possible HCM symptoms of HCM a first-degree relative with HCM First-degree relatives ...

Ischemic cardiomyopathy (ICM) is the end stage of ischemic heart ... Here, we aim to investigate whether LIPUS can perform cardiac protective effects in ICM and explore its possible mechanism. The ...

More than 34% of 'red flags' found in patients consistent with a suspicion of hypertrophic cardiomyopathy (HCM ... with access to diagnostic tools such as 12-lead electrocardiogram (ECG) and ...

Hypertrophic cardiomyopathy (HCM) is associated with risk of sudden cardiac death (SCD) due to ventricular arrhythmias (VAs) arising from the proliferation of fibrosis in the heart. Current clinical ...